NASDAQ

Kyverna Therapeutics, Inc. (KYTX)

♥ 630 Thanks from members

Live price chart, market sentiment, and community perspectives for Kyverna Therapeutics, Inc. (NASDAQ: KYTX).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Aksel BuchwaldtFounder: Marco SchitoLeadership: Peter Maag (CEO)Leadership: Dara Moskowitz (CMO)Holder: Bain Capital Life SciencesHolder: Sofinnova InvestmentsHolder: Venrock Healthcare CapitalKYV-101Autologous CD19 CAR-T Cell Therapy#KYTX stock#Kyverna Therapeutics#CAR-T therapy#autoimmune disease#biotech IPO